The Health Resources and Services Administration (HRSA) has named 10 pharmaceutical manufacturers and 21 drugs that will participate in its revised 340B Rebate Model Pilot Program, scheduled to begin January 1, 2027.
HRSA published the participant list on October 2, providing details on a program that will replace traditional upfront 340B discounts with a
Under